Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.22 and traded as high as $0.22. Acerus Pharmaceuticals shares last traded at $0.22, with a volume of 0 shares traded.
Acerus Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 0.64, a current ratio of 1.35 and a quick ratio of 0.90. The stock has a market capitalization of $56.90 million, a price-to-earnings ratio of -2.75 and a beta of 2.60. The firm’s fifty day moving average is $0.22 and its 200-day moving average is $0.22.
Acerus Pharmaceuticals Company Profile
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.
Featured Articles
- Five stocks we like better than Acerus Pharmaceuticals
- With Risk Tolerance, One Size Does Not Fit All
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- ETF Screener: Uses and Step-by-Step Guide
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How to Invest in the Best Canadian Stocks
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
